title: [Therapy of venous hypertension in animals with an artificial heart and long-term survival].
abstract: 1. The authors elaborated an original concept for the interpretation of vasomotor disorders in subjects with an artificial heart. 2. This concept is based on the regeneration of nervous elements in the walls of the atria (in particular the right one) after implantation of the artificial heart and on comparison of their activity with the venous pressure which revealed the interrelationship of the two phenomena. 3. Both therapeutic methods based on this concept, the method of influencing the afferentation and efferentation of vasomotor nervous regulations leading to a reduction of the central venous pressure proved valid and effective. 4. Evaluation of the effectiveness of this therapy is based on regular assessment of the central venous pressure, on the laboratory assay of enzymes (AST, ALT, GMT and LDH), on the assessment of serum albumin and finally on the morphological and histological examination of the liver incl. assessment of the hepatic index. 5. The nervous pathogenesis is closely linked with hormonal factors. The latter are conceived as the participation of associated factors in the pathogenesis of venous hypertension in recipients with an artificial heart.
authors.forename: J
authors.initials: J
authors.lastname: Vasků
authors.forename: J
authors.initials: J
authors.lastname: Vasků
authors.forename: M
authors.initials: M
authors.lastname: Dostál
authors.forename: J
authors.initials: J
authors.lastname: Rebícek
authors.forename: J
authors.initials: J
authors.lastname: Cerný
authors.forename: Z
authors.initials: Z
authors.lastname: Gregor
authors.forename: P
authors.initials: P
authors.lastname: Guba
authors.forename: O
authors.initials: O
authors.lastname: Sotolová
authors.forename: A
authors.initials: A
authors.lastname: Vasků
authors.forename: P
authors.initials: P
authors.lastname: Urbánek
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use; D002417:Cattle; D003000:Clonidine / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D006354:Heart, Artificial / Q000009:adverse effects*; D008750:Methyldopa / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014690:Venous Pressure / Q000187:drug effects*
chemical_list: D000959:Antihypertensive Agents; D008750:Methyldopa; D002216:Captopril; D004110:Diltiazem; D009543:Nifedipine; D003000:Clonidine; D011224:Prazosin
vernacular_title: K terapii zilní hypertenze u zvírat dlouhodobĕ prezívajících s totální náhradou srdce.